Dr. Kamala Maddali is a biotech, pharma, diagnostics and life sciences executive and board advisor with over 17 years of deep expertise in Precision Medicine.
Prior to Deep Lens, Dr. Maddali served as a chief scientific and commercial executive for many notable Fortune 500 companies like Merck and Co., Quintiles and Quest Diagnostics where she led strategic initiatives to foster positive growth in precision medicine. She also served as an executive advisor for several other healthcare technology companies focused in artificial intelligence, blockchain genomics, nutraceuticals, bioinformatics, biotechs focused on unique precision medicine driven solutions.
Dr. Maddali has a Ph.D. in Pharmacology from University of Missouri-Columbia and a doctorate in Veterinary Medicine from Tirupati, India. She brings unique experience across precision medicine and education from her personal battle as a “Rare Disease patient” herself.
She is an active leader in precision medicine and a patient advocate serving as a board member for several US/International based organizations working to foster knowledge about cancer, rare disease diagnosis and prevention, and disease management.
Dr. Maddali has received national recognition from her accomplishments, most notably the 2016 Healthcare Heroes Finalist Award for “Innovation-Individual” category at NJBIZ, the closing bell ceremony for the NYSE stock exchange in 2017 and was interviewed by CNBC in December 2018 on Precision Medicine advancements and Blockchain.
She is a pioneer in the space and a patient advocate, on a mission to help patients with powerful tools from science and innovation for improving global community health.